D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 76 800 KRW 3.5% Market Closed
Market Cap: 689.4B KRW
Have any thoughts about
Dong-A ST Co Ltd?
Write Note

Relative Value

The Relative Value of one Dong-A ST Co Ltd stock under the Base Case scenario is 100 801.35 KRW. Compared to the current market price of 76 800 KRW, Dong-A ST Co Ltd is Undervalued by 24%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
100 801.35 KRW
Undervaluation 24%
Relative Value
Price
D
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
49
vs Industry
72
Median 3Y
0.9
Median 5Y
1
Industry
2.6
Forward
1
vs History
vs Industry
8
Median 3Y
37.3
Median 5Y
23.4
Industry
22.3
Forward
23.6
vs History
vs Industry
2
Median 3Y
10.7
Median 5Y
11.7
Industry
17.5
vs History
41
vs Industry
31
Median 3Y
5.5
Median 5Y
4.5
Industry
24.8
vs History
30
vs Industry
64
Median 3Y
0.8
Median 5Y
0.9
Industry
2.1
vs History
50
vs Industry
78
Median 3Y
0.7
Median 5Y
0.8
Industry
2.7
Forward
0.8
vs History
49
vs Industry
76
Median 3Y
1.5
Median 5Y
1.6
Industry
5.3
vs History
6
vs Industry
13
Median 3Y
13.2
Median 5Y
12.6
Industry
13.4
Forward
9.1
vs History
vs Industry
10
Median 3Y
28.3
Median 5Y
16.4
Industry
16.8
Forward
17.5
vs History
vs Industry
2
Median 3Y
8.8
Median 5Y
11.1
Industry
15.9
vs History
vs Industry
Median 3Y
-12.4
Median 5Y
-9.8
Industry
18.5
vs History
57
vs Industry
74
Median 3Y
0.6
Median 5Y
0.6
Industry
1.9

Multiples Across Competitors

Competitors Multiples
Dong-A ST Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
Dong-A ST Co Ltd
KRX:170900
660.4B KRW 1 -98.9 55.6 -30.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
793.7B USD 20.4 108.1 54.1 60.6
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.4T DKK 13.1 37.5 25 28.7
US
Johnson & Johnson
NYSE:JNJ
385.5B USD 4.4 26.3 12.7 16.5
US
Merck & Co Inc
NYSE:MRK
260.6B USD 4.2 19 12.9 15.8
CH
Roche Holding AG
SIX:ROG
213.6B CHF 3.6 18.6 10.4 12.4
UK
AstraZeneca PLC
LSE:AZN
171.2B GBP 4.5 34.5 170.6 255.7
CH
Novartis AG
SIX:NOVN
183.5B CHF 4.3 13.1 10.4 15.4
US
Pfizer Inc
NYSE:PFE
161.4B USD 2.7 38 11.1 16.7
P/E Multiple
Earnings Growth
KR
D
Dong-A ST Co Ltd
KRX:170900
Average P/E: 36.9
Negative Multiple: -98.9
331%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
108.1
454%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
37.5
89%
US
Johnson & Johnson
NYSE:JNJ
26.3
-22%
US
Merck & Co Inc
NYSE:MRK
19
7 426%
CH
Roche Holding AG
SIX:ROG
18.6
30%
UK
AstraZeneca PLC
LSE:AZN
34.5
175%
CH
Novartis AG
SIX:NOVN
13.1
19%
US
Pfizer Inc
NYSE:PFE
38
712%
EV/EBIT Multiple
EBIT Growth
KR
D
Dong-A ST Co Ltd
KRX:170900
Average EV/EBIT: 2 013.8
Negative Multiple: -30.2
352%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 046 864.6 N/A
US
Eli Lilly and Co
NYSE:LLY
60.6
212%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
675%
DK
Novo Nordisk A/S
CSE:NOVO B
28.7
85%
US
Johnson & Johnson
NYSE:JNJ
16.5
29%
US
Merck & Co Inc
NYSE:MRK
15.8
695%
CH
Roche Holding AG
SIX:ROG
12.4
27%
UK
AstraZeneca PLC
LSE:AZN
255.7
131%
CH
Novartis AG
SIX:NOVN
15.4
54%
US
Pfizer Inc
NYSE:PFE
16.7
63%

See Also

Discover More
Back to Top